地拉罗司怎么购买呢？

Also known as Enrig, it is mainly used to treat chronic iron overload caused by frequent blood transfusions (monthly administration of concentrated red blood cells ≥7mL/kg) in patients with β-thalassemia older than 6 years old; for children under 6 years old and iron overload caused by other transfusion-dependent diseases. Studies have shown that deferasirox has a very good therapeutic effect and is the most effective among oral drugs. Because deferasirox persists in the plasma, it can continuously reduce plasma non-transferrin-bound iron and directly remove iron formed from toxicity in the body, which can effectively alleviate the condition of our patients in a timely manner. How to buy deferasirox?

Deferasirox has been launched in China. According to the latest data sampling, the domestic specifications of Deferasirox are 125mg/tablet-28 tablets/bottle (box), and the price is 2330$; Deferasirox It requires the patient to take it continuously, which in the long run will be a heavy financial burden for the patient; then turn to India: Deferasirox from Novartis in Switzerland, the specification is 400mg*30 tablets/box, and the price is about $700. The specification of Deferasirox in India is 500*30 tablets/box, and the price is about $500. It is extremely cost-effective and reduces the financial pressure on patients to a great extent!

If Chinese patients want to buy Indian Deferasirox, they can prepare relevant strategies for going abroad to see a doctor, go to a regular hospital in India for consultation in person, and then get the medicine. If the patient has no relevant experience in going abroad and is worried about the language barrier and cannot communicate with Indian doctors, he or she can also seek help from regular domestic medical institutions. The staff of the medical institution will solve the patient's related problems.

Finally, I would like to remind all patients with severe thalassemia that in our daily blood transfusion treatment, the frequency of blood transfusion can also affect the effect of controlling liver concentration. When the iron intake is greater than 0.5mg/(kg·d), only 47% of patients who receive the same dose of deferasirox have a reduction in liver concentration. Therefore, during our medication treatment, in addition to having correct medication instructions, we also need to treat under the guidance of a doctor. We must not blindly take medication by ourselves.